Xeris Biopharma Holdings, Inc. (XERS)
6.07
+0.13
(+2.19%)
USD |
NASDAQ |
Mar 04, 16:00
6.10
+0.03
(+0.49%)
After-Hours: 20:00
Xeris Biopharma Holdings Research and Development Expense (Annual) : 31.16M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| IDEXX Laboratories, Inc. | 251.21M |
| Harrow, Inc. | 15.05M |
| Vir Biotechnology, Inc. | 432.80M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |